Scarica l'app Stockscreener
35.25
0.79%
-0.28
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$35.53
Aprire:
$35.07
Volume 24 ore:
344.31K
Relative Volume:
0.32
Capitalizzazione di mercato:
$1.72B
Reddito:
$96.21M
Utile/perdita netta:
$-12.13M
Rapporto P/E:
-112.62
EPS:
-0.313
Flusso di cassa netto:
$10.64M
1 W Prestazione:
-3.11%
1M Prestazione:
+8.39%
6M Prestazione:
+70.54%
1 anno Prestazione:
+36.26%
Intervallo 1D:
$34.89
$35.52
Intervallo di 1 settimana:
$34.89
$37.25
Portata 52W:
$17.86
$38.10
Biolife Solutions Inc Stock (BLFS) Company Profile
Nome
Biolife Solutions Inc
Settore
Industria
Telefono
(425) 401-1400
Indirizzo
3303 MONTE VILLA PARKWAY, BOTHELL, WA
Compare BLFS vs ISRG, BDX, ALC, RMD, MDLN
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BLFS
Biolife Solutions Inc
|
35.25 | 1.81B | 96.21M | -12.13M | 10.64M | -0.313 |
ISRG
Intuitive Surgical Inc
|
366.70 | 132.30B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
184.74 | 51.11B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
70.50 | 35.25B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
228.35 | 32.95B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
36.59 | 28.58B | 29.14B | 1.07B | 1.05B | 1.1956 |
Biolife Solutions Inc Stock (BLFS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-22 | Ripresa | Stephens | Overweight |
| 2024-09-30 | Iniziato | H.C. Wainwright | Buy |
| 2024-04-04 | Iniziato | Jefferies | Buy |
| 2023-07-11 | Iniziato | Craig Hallum | Buy |
| 2022-04-25 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2021-10-19 | Iniziato | B. Riley Securities | Buy |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-05-14 | Downgrade | The Benchmark Company | Buy → Hold |
| 2021-03-23 | Aggiornamento | The Benchmark Company | Hold → Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-09-22 | Downgrade | Oppenheimer | Outperform → Perform |
| 2020-09-18 | Iniziato | Cowen | Outperform |
| 2020-08-11 | Downgrade | The Benchmark Company | Buy → Hold |
| 2020-07-08 | Reiterato | Maxim Group | Buy |
| 2020-02-24 | Iniziato | Lake Street | Buy |
| 2020-02-19 | Iniziato | The Benchmark Company | Buy |
| 2020-02-06 | Ripresa | B. Riley FBR | Buy |
| 2020-01-08 | Iniziato | Stephens | Overweight |
| 2019-11-21 | Iniziato | Oppenheimer | Outperform |
| 2019-07-22 | Iniziato | H.C. Wainwright | Buy |
| 2017-11-10 | Reiterato | Maxim Group | Buy |
| 2017-09-19 | Reiterato | Maxim Group | Buy |
| 2017-07-05 | Aggiornamento | Janney | Neutral → Buy |
| 2017-03-10 | Reiterato | Maxim Group | Buy |
| 2017-01-19 | Iniziato | Maxim Group | Buy |
Mostra tutto
Biolife Solutions Inc Borsa (BLFS) Ultime notizie
Bank of America Corp DE Increases Stake in BioLife Solutions, Inc. $BLFS - MarketBeat
Summit Creek Advisors LLC Acquires New Position in BioLife Solutions, Inc. $BLFS - MarketBeat
BioLife Solutions Reports Fourth Quarter and Full Year 2025 Fina - GuruFocus
Diamond Hill Capital Management LLC Investment Advisor Acquires New Stake in BioLife Solutions, Inc. $BLFS - MarketBeat
Short Interest in BioLife Solutions, Inc. (NASDAQ:BLFS) Rises By 59.1% - MarketBeat
BLFS Q2 2026 Earnings: EPS Beats Consensus by 17.65% as Shares Gain 1.08%Earnings Call Q&A - vinanet.vn
BioLife Solutions (NASDAQ:BLFS) Reaches New 12-Month HighShould You Buy? - MarketBeat
Biolife Solutions stock hits 52-week high at 35.36 USD By Investing.com - Investing.com South Africa
Biolife Solutions stock hits 52-week high at 35.36 USD - Investing.com
BioLife’s Sharp Swing To Profit Might Change The Case For Investing In BioLife Solutions (BLFS) - simplywall.st
Roubaix Capital, LLC's BioLife Solutions Inc(BLFS) Holding History - GuruFocus
BioLife Solutions, Inc. (NASDAQ:BLFS) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
BioLife Solutions, Inc. (BLFS) Stock Forecasts - Yahoo! Finance Canada
BioLife Solutions, Inc. (BLFS) Stock Analysis: Navigating a High Forward P/E Amid Robust Growth in the Healthcare Sector - DirectorsTalk Interviews
BioLife Solutions (NASDAQ:BLFS) Hits New 12-Month HighTime to Buy? - MarketBeat
BioLife Solutions Cut to Hold From Buy by Benchmark - Moomoo
Why BioLife Solutions (BLFS) Is Up 7.8% After Swinging To Q2 Profitability And What's Next - simplywall.st
Benchmark Co. Downgrades BioLife Solutions(BLFS.US) to Hold Rating - Moomoo
BioLife Solutions (BLFS) Stock Price Ignores A Sharp Turn To Profit - simplywall.st
BioLife Solutions Inc (BLFS) Stock News Today - TradingKey
BioLife Solutions Inc (BLFS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Royal Bank of Canada Purchases 66,010 Shares of BioLife Solutions, Inc. $BLFS - MarketBeat
BLFS Looks 16.4% Overvalued on GF Value™ Amid Strong Q2 Revenue Beat - GuruFocus
BioLife Solutions (BLFS) Is Up 7.2% After Swinging From Loss To Q2 ProfitWhat's Changed - Yahoo Finance
Is BioLife Solutions Inc (BLFS) Overvalued After Q2 Earnings Bea - GuruFocus
BLFS SWOT Analysis: Strong Revenue Growth Amidst Strategic Changes Revealed in 10-Q Filing - GuruFocus
BioLife Solutions (NASDAQ:BLFS) Posts Earnings Results, Beats Estimates By $0.88 EPS - MarketBeat
BLFS Technical Analysis & Stock Price Forecast - Intellectia AI
BioLife Solutions, Inc. (BLFS) Q2 Earnings and Revenues Surpass Estimates - Yahoo Finance
BioLife Solutions, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
BioLife Solutions 2026: Revenue $28.47M, EPS $0.91— 10-Q Summary - TradingView
Earnings Flash (BLFS) BioLife Solutions, Inc. Reports Q2 Revenue $28.5M, vs. FactSet Est of $27.8M - marketscreener.com
BIOLIFE SOLUTIONS ($BLFS) Releases Q2 2026 Earnings - Quiver Quantitative
BioLife Solutions (NASDAQ: BLFS) plans cash-stock merger with Repligen - Stock Titan
BioLife Solutions reports Q2 2026 revenue $28.5M, GAAP net income $45.1M, adjusted EBITDA $7.4M - TradingView
BioLife Solutions, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
BLFS: Q2 2026 revenue up 21% year-over-year; $1.5B acquisition by Repligen set for Q4 2026 - TradingView
BioLife Solutions (NASDAQ:BLFS) Hits New 52-Week HighStill a Buy? - MarketBeat
BioLife Solutions set to report earnings under takeover cloud By Investing.com - Investing.com Nigeria
Biolife Solutions stock hits 52-week high at 33.18 USD - Investing.com
Biolife Solutions stock hits 52-week high at 33.18 USD By Investing.com - Investing.com South Africa
BioLife Solutions set to report earnings under takeover cloud - Investing.com
Repligen Corporation (BLFS) sets cash and stock terms for BioLife Solutions buyout - stocktitan.net
BioLife Solutions, Inc. (BLFS) Stock Analysis: Navigating Growth with Precision in the Healthcare Sector - DirectorsTalk Interviews
Repligen to acquire BioLife Solutions in two-step merger; employee video details timeline - TradingView
BLFS Q1 2026 Earnings: Marginal EPS Miss Highlights Narrow Beat-and-Miss GapEarnings Miss Streak - Vinanet
BioLife Solutions, Inc. Revenue Breakdown – NASDAQ:BLFS - TradingView
BLFS Q1 2026 Earnings: EPS of $0.02 Slightly Misses Consensus EstimatesShort-Term Outlook - Vinanet
BLFS Q2'26 Earnings: revenue estimate is 27.80M USD - TradingView
Avoiding Lag: Real-Time Signals in (BLFS) Movement - Stock Traders Daily
Biolife Solutions stock hits 52-week high at 32.24 USD By Investing.com - Investing.com South Africa
Biolife Solutions Inc Azioni (BLFS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Biolife Solutions Inc Azioni (BLFS) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Casdin Partners Master Fund, L | 10% Owner |
May 19 '26 |
Sale |
22.65 |
300,000 |
6,795,000 |
5,657,165 |
| Casdin Partners Master Fund, L | 10% Owner |
May 20 '26 |
Sale |
23.70 |
250,000 |
5,925,000 |
5,407,165 |
0.76%
1.02%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):